Exagen Inc
NASDAQ:XGN

Watchlist Manager
Exagen Inc Logo
Exagen Inc
NASDAQ:XGN
Watchlist
Price: 7.12 USD 2.01% Market Closed
Market Cap: 155.2m USD

Wall Street
Price Targets

XGN Price Targets Summary
Exagen Inc

Wall Street analysts forecast XGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XGN is 7.91 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

Lowest
Price Target
7.07 USD
1% Downside
Average
Price Target
7.91 USD
11% Upside
Highest
Price Target
9.45 USD
33% Upside
Exagen Inc Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
46% Upside
6855
Ascentage Pharma Group International
11% Downside
CDNA
CareDx Inc
57% Upside
NIOX
Niox Group PLC
18% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
32% Upside
BPMC
Blueprint Medicines Corp
0% Downside
145020
Hugel Inc
19% Upside
87S
Roivant Sciences Ltd
60% Upside

Revenue
Forecast

Revenue Estimate
Exagen Inc

For the last 10 years the compound annual growth rate for Exagen Inc's revenue is 17%. The projected CAGR for the next 3 years is 15%.

17%
Past Growth
15%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Exagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Exagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XGN's stock price target?
Price Target
7.91 USD

According to Wall Street analysts, the average 1-year price target for XGN is 7.91 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

What is Exagen Inc's Revenue forecast?
Projected CAGR
15%

For the last 10 years the compound annual growth rate for Exagen Inc's revenue is 17%. The projected CAGR for the next 3 years is 15%.

Back to Top